Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus

• Steven S. Good ,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft

  * E-mail: good.steven@ateapharma.com

  Affiliation Atea Pharmaceuticals, Inc., Boston, Massachusetts, United States of America

  http://orcid.org/0000-0003-1476-9892

  ⨯
• Adel Moussa,

  Roles Conceptualization, Formal analysis, Resources, Writing – review & editing

  Affiliation Atea Pharmaceuticals, Inc., Boston, Massachusetts, United States of America

  ⨯
• Xiao-Jian Zhou,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliation Atea Pharmaceuticals, Inc., Boston, Massachusetts, United States of America

  ⨯
• Keith Pietropaolo,

  Roles Data curation, Project administration, Writing – review & editing

  Affiliation Atea Pharmaceuticals, Inc., Boston, Massachusetts, United States of America

  ⨯
• Jean-Pierre Sommadossi

  Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing

  Affiliation Atea Pharmaceuticals, Inc., Boston, Massachusetts, United States of America

  ⨯